Target intelligence / Profile preview

Large subunit of bacterial ribosome (50S ribosomal subunit)

Target
50S ribosomal subunit
Molecular classification
Ribosome component, Ribozyme (catalytic RNA-protein complex), Other
01

Overview

The **large subunit of the bacterial ribosome** (commonly called the **50S ribosomal subunit**) is one half of the prokaryotic ribosome, a complex molecular machine essential for protein synthesis in all living bacteria[1][6][7]. The 50S subunit is composed mainly of *23S* and *5S ribosomal RNA* molecules and approximately 31 proteins[6]. It joins with the small subunit (30S) during translation to form the functional 70S ribosome[1][6]. The most critical catalytic function of the 50S subunit is its **peptidyl transferase center**, a ribozyme region responsible for forming peptide bonds between amino acids, thus elongating the nascent protein chain[2][6]. Many antibiotics, including macrolides and chloramphenicol, target this subunit, inhibiting bacterial protein synthesis and making it a central therapeutic target in infectious disease management[6]. Key safety concerns with drugs targeting this subunit involve potential bacterial resistance due to mutations, though generally, selectivity for the bacterial ribosome limits toxicity to human cells[6][7].

Other names
50S subunit50S ribosomal subunitProkaryotic large ribosomal subunit
02

Mechanism of action

Inhibition of protein synthesis by binding to the large ribosomal subunit, blocking peptide bond formation or exit tunnel for nascent polypeptide chain

03

Biological functions

Protein synthesis (translation)Peptide bond formationmRNA decoding (in part)Catalysis of peptidyl transferase reaction
04

Disease associations

InfectionAntibiotic resistanceOther
05

Safety considerations

Selectivity: Off-target toxicity minimized, as these drugs generally do not affect eukaryotic (human) ribosomesResistance: Mutations in rRNA or ribosomal proteins can lead to drug resistanceMicrobiome disturbance due to broad-spectrum antibiotic action
06

Interacting drugs

Macrolide antibiotics (e.g., erythromycin, azithromycin)

5 more in the full profile.

07

Biomarkers

Presence of 23S rRNA gene (for bacterial identification and drug resistance testing)Mutations in 23S rRNA or ribosomal protein genes (for antibiotic resistance)

Beyond the preview

Go deeper on Large subunit of bacterial ribosome (50S ribosomal subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large subunit of bacterial ribosome (50S ribosomal subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call